Treatment  	Treatment  	 NN	B-NP
goals  	goals  	 NNS	I-NP
in  	in  	 IN	O
psoriasis  	psoriasis  	 JJ	B-NP
routine  	routine  	 JJ	I-NP
care  	care  	 NN	I-NP
The  	The  	 DT	O
treatment  	treatment  	 NN	B-NP
goal  	goal  	 NN	I-NP
algorithm  	algorithm  	 NN	I-NP
for  	for  	 IN	I-NP
psoriasis 	psoriasis 	 NN	I-NP
,  	,  	 ,	O
first  	first  	 RB	O
originated  	originated  	 VBN	O
in  	in  	 IN	O
2007 	2007 	 CD	O
,  	,  	 ,	O
has  	has  	 VBZ	O
ever  	ever  	 RB	O
since  	since  	 IN	O
been  	been  	 VBN	O
adopted  	adopted  	 VBN	O
into  	into  	 IN	O
treatment  	treatment  	 NN	B-NP
guidelines 	guidelines 	 NNS	I-NP
.  	.  	 .	O
It  	It  	 PRP	O
remained  	remained  	 VBD	O
unclear  	unclear  	 JJ	O
how  	how  	 WRB	O
many  	many  	 JJ	O
patients  	patients  	 NNS	O
have  	have  	 VBP	O
experienced  	experienced  	 VBN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
goals  	goals  	 NNS	I-NP
in  	in  	 IN	O
routine  	routine  	 JJ	B-NP
care  	care  	 NN	I-NP
and  	and  	 CC	O
how  	how  	 WRB	O
these  	these  	 DT	O
are  	are  	 VBP	O
perceived 	perceived 	 VBN	O
.  	.  	 .	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
pilot  	pilot  	 NN	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
get  	get  	 VB	O
first  	first  	 JJ	O
insight  	insight  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
and  	and  	 CC	O
impact  	impact  	 NN	O
of  	of  	 IN	O
therapeutic  	therapeutic  	 JJ	B-NP
goals  	goals  	 NNS	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
psoriasis  	psoriasis  	 NN	B-NP
in  	in  	 IN	O
routine  	routine  	 JJ	B-NP
care 	care 	 NN	I-NP
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
is  	is  	 VBZ	O
a  	a  	 DT	O
multicenter 	multicenter 	 NN	B-NP
,  	,  	 ,	O
non-interventional 	non-interventional 	 NNP	B-NP
,  	,  	 ,	O
cross-sectional  	cross-sectional  	 JJ	B-NP
health  	health  	 NN	I-NP
care  	care  	 NN	I-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
n  	n  	 CD	O
=  	=  	 SYM	O
213  	213  	 CD	O
dermatology  	dermatology  	 CD	O
centers  	centers  	 NNS	O
across  	across  	 IN	O
Germany 	Germany 	 NNP	O
.  	.  	 .	O
A  	A  	 DT	O
standardized  	standardized  	 JJ	O
physician  	physician  	 NN	O
and  	and  	 CC	O
patient  	patient  	 JJ	O
questionnaire  	questionnaire  	 NN	O
was  	was  	 VBD	O
used 	used 	 VBN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
demographics 	demographics 	 NNS	I-NP
,  	,  	 ,	O
disease  	disease  	 NN	O
and  	and  	 CC	O
treatment  	treatment  	 NN	B-NP
characteristics 	characteristics 	 NNS	I-NP
.  	.  	 .	O
To  	To  	 TO	O
evaluate  	evaluate  	 VB	O
patient  	patient  	 JJ	O
treatment  	treatment  	 NN	B-NP
perception  	perception  	 NN	I-NP
and  	and  	 CC	O
satisfaction 	satisfaction 	 NN	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
questionnaire  	questionnaire  	 NN	O
( 	( 	 -LRB-	O
PsoSat 	PsoSat 	 NNP	B-NP
)  	)  	 -RRB-	O
addressing  	addressing  	 VBG	O
8  	8  	 CD	O
specific  	specific  	 JJ	O
items  	items  	 NNS	O
was  	was  	 VBD	O
designed 	designed 	 VBN	O
.  	.  	 .	O
Consistency  	Consistency  	 NNP	O
and  	and  	 CC	O
validity  	validity  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
questionnaire  	questionnaire  	 NN	O
were  	were  	 VBD	O
controlled  	controlled  	 VBN	O
by  	by  	 IN	O
factor  	factor  	 NN	B-NP
analyses  	analyses  	 NNS	I-NP
and  	and  	 CC	O
reliability  	reliability  	 JJ	B-NP
tests 	tests 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
total  	total  	 JJ	B-NP
n  	n  	 NN	I-NP
=  	=  	 SYM	O
1,883  	1,883  	 CD	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
included  	included  	 VBN	O
for  	for  	 IN	O
analysis  	analysis  	 NN	O
( 	( 	 -LRB-	O
54.2 	54.2 	 NNP	O
%  	%  	 NN	O
male 	male 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mean  	Mean  	 JJ	B-NP
age  	age  	 NN	I-NP
was  	was  	 VBD	O
52  	52  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
mean  	mean  	 JJ	O
disease  	disease  	 NN	B-NP
duration  	duration  	 NN	I-NP
19  	19  	 CD	O
years 	years 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
total  	total  	 JJ	O
45.5 	45.5 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
856 	856 	 CD	O
)  	)  	 -RRB-	O
stated  	stated  	 VBD	O
an  	an  	 DT	O
improvement  	improvement  	 NN	O
of  	of  	 IN	O
psoriatic  	psoriatic  	 JJ	B-NP
symptoms  	symptoms  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
4  	4  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
patients  	patients  	 NNS	O
including  	including  	 VBG	B-NP
treatment  	treatment  	 NN	I-NP
goals 	goals 	 NNS	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
course  	course  	 NN	O
of  	of  	 IN	O
psoriasis  	psoriasis  	 NN	B-NP
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
4  	4  	 CD	O
weeks  	weeks  	 NNS	O
was  	was  	 VBD	O
rated  	rated  	 VBN	O
significantly  	significantly  	 RB	O
better  	better  	 JJR	O
and  	and  	 CC	O
predicted  	predicted  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
patient  	patient  	 NN	O
satisfaction 	satisfaction 	 NN	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
reporting  	reporting  	 VBG	O
periodic  	periodic  	 JJ	B-NP
outcomes  	outcomes  	 JJ	I-NP
measurement  	measurement  	 NN	I-NP
of  	of  	 IN	I-NP
psoriasis  	psoriasis  	 JJ	I-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
also  	also  	 RB	O
had  	had  	 VBD	O
significantly  	significantly  	 RB	O
better  	better  	 JJR	O
course  	course  	 NN	O
of  	of  	 IN	O
disease 	disease 	 NN	O
,  	,  	 ,	O
higher  	higher  	 JJR	O
satisfaction  	satisfaction  	 NN	B-NP
and  	and  	 CC	O
a  	a  	 DT	O
lower  	lower  	 JJR	O
psoriasis  	psoriasis  	 JJ	B-NP
severity 	severity 	 NN	I-NP
.  	.  	 .	O
A  	A  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
experienced  	experienced  	 VBD	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
goals  	goals  	 NNS	I-NP
in  	in  	 IN	O
practice 	practice 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
association  	association  	 NN	O
of  	of  	 IN	O
using  	using  	 VBG	O
treatment  	treatment  	 NN	B-NP
goals  	goals  	 NNS	I-NP
with  	with  	 IN	O
clinical  	clinical  	 JJ	B-NP
outcomes  	outcomes  	 NNS	I-NP
and  	and  	 CC	O
treatment  	treatment  	 NN	B-NP
satisfaction  	satisfaction  	 NN	I-NP
was  	was  	 VBD	O
markedly  	markedly  	 RB	O
positive 	positive 	 JJ	O
.  	.  	 .	O
These  	These  	 DT	O
findings  	findings  	 NNS	O
indicate  	indicate  	 VBP	O
that  	that  	 IN	O
the  	the  	 DT	O
use  	use  	 NN	O
of  	of  	 IN	O
treatment  	treatment  	 NN	B-NP
goals  	goals  	 NNS	I-NP
and  	and  	 CC	O
outcome  	outcome  	 NN	B-NP
measurements  	measurements  	 NNS	I-NP
in  	in  	 IN	O
fact  	fact  	 NN	O
improve  	improve  	 VB	O
psoriasis  	psoriasis  	 JJ	B-NP
management 	management 	 NN	I-NP
.  	.  	 .	O
